The “Global Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)” report provides an in depth analysis of the global oral insulin market by value, by region, etc. The report provides a regional analysis of the oral insulin market, including the following regions: North America (The US, Mexico, and Canada); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific); and ROW (Brazil, Saudi Arabia, South Africa, and ROW Countries). The report also provides a detailed analysis of the COVID-19 impact on the oral insulin market.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global oral insulin market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global oral insulin market is consolidated with few major market players operating worldwide. The key players of the oral insulin market are Novo Nordisk A/S, Oramed Pharmaceuticals Inc., vTv Therapeutics, and Diabetology Ltd. are also profiled with their financial information and respective business strategies.
Country Coverage
- North America
- Europe
- Asia Pacific
- Rest of World
Company Coverage
- Novo Nordisk A/S
- Oramed Pharmaceuticals Inc.
- vTv Therapeutics
- Diabetology Ltd.
The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
The oral insulin market can be segmented on the basis of application (Type 1 diabetes and Type 2 diabetes); and gender (Female and Male).
The global oral insulin market has increased significantly during the years 2019-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The oral insulin market is expected to increase due to rapid urbanization, escalating healthcare spending, increasing prevalence of diabetes, favorable government initiatives, advantages of oral insulin over injectable insulin, etc. Yet the market faces some challenges such as uncertainty around getting the FDA approval, low oral bioavailability, etc.
Table of Contents
1. Executive Summary
2. Introduction
2.1 Diabetes Mellitus: An Overview
2.2 Insulin: An Overview
2.2.1 Kinds of Insulin Formulations
2.3 Oral Insulin: An Overview
2.3.1 Types of Oral Insulin
2.3.2 Advantages of Oral Insulin Treatment
2.4 Oral Insulin Segmentation: An Overview
2.4.1 Oral Insulin Segmentation
3. Global Market Analysis
3.1 Global Oral Insulin Market: An Analysis
3.1.1 Global Oral Insulin Market by Value
3.1.2 Global Oral Insulin Market by Region (North America, Europe, Asia Pacific, and Rest of World)
4. Regional Market Analysis
4.1 North America Oral Insulin Market: An Analysis
4.1.1 North America Oral Insulin Market by Value
4.1.2 North America Oral Insulin Market by Region (The US, Mexico, and Canada)
4.1.3 The US Oral Insulin Market by Value
4.1.4 Canada Oral Insulin Market by Value
4.1.5 Mexico Oral Insulin Market by Value
4.2 Europe Oral Insulin Market: An Analysis
4.2.1 Europe Oral Insulin Market by Value
4.2.2 Europe Oral Insulin Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe)
4.2.3 Germany Oral Insulin Market by Value
4.2.4 UK Oral Insulin Market by Value
4.2.5 France Oral Insulin Market by Value
4.2.6 Italy Oral Insulin Market by Value
4.2.7 Spain Oral Insulin Market by Value
4.2.8 Rest of Europe Oral Insulin Market by Value
4.3 Asia Pacific Oral Insulin Market: An Analysis
4.3.1 Asia Pacific Oral Insulin Market by Value
4.3.2 Asia Pacific Oral Insulin Market by Region (China, Japan, India, Australia, South Korea and Rest of Asia Pacific)
4.3.3 China Oral Insulin Market by Value
4.3.4 Japan Oral Insulin Market by Value
4.3.5 India Oral Insulin Market by Value
4.3.6 Australia Oral Insulin Market by Value
4.3.7 South Korea Oral Insulin Market by Value
4.3.8 Rest of Asia Pacific Oral Insulin Market by Value
4.4 ROW Oral Insulin Market: An Analysis
4.4.1 ROW Oral Insulin Market by Value
4.4.2 ROW Oral Insulin Market by Region (Brazil, Saudi Arabia, South Africa, and ROW countries)
4.4.3 Brazil Oral Insulin Market by Value
4.4.4 Saudi Arabia Oral Insulin Market by Value
4.4.5 South Africa Oral Insulin Market by Value
4.4.6 ROW Countries Oral Insulin Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Healthcare Sector
5.1.2 Impact of COVID-19 on Diabetic Patients
5.1.3 Impact of COVID-19 on Oral Insulin
6. Market Dynamics
6.1 Growth Driver
6.1.1 Rapid Urbanization
6.1.2 Increasing Prevalence of Diabetes
6.1.3 Escalating Healthcare Spending
6.1.4 Favorable Government Initiatives
6.1.5 Advantages of Oral Insulin over Injectable Insulin
6.2 Challenges
6.2.1 Uncertainty around Getting the FDA Approval
6.2.2 Low Oral Bioavailability
6.3 Market Trends
6.3.1 Increasing Demand for Oral Spray
6.3.2 Growing Use of Oral Insulin Capsule for the Treatment of Nonalcoholic Steatohepatitis (NASH)
6.3.3 Innovations in the Delivery of Oral Insulin
7. Competitive Landscape
7.1 Global Oral Insulin Market Players: A Financial Comparison
7.2 Global Oral Insulin Market Players by Oral Drugs-related Clinical Trials
8. Company Profiles
8.1 Novo Nordisk A/S
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Oramed Pharmaceuticals Inc.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 vTv Therapeutics
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Diabetology Ltd
8.4.1 Business Overview
List of Figures
Figure 1: Kinds of Insulin Formulations
Figure 2: Types of Oral Insulin
Figure 3: Oral Insulin Segmentation
Figure 4: Global Oral Insulin Market by Value; 2019-2020 (US$ Billion)
Figure 5: Global Oral Insulin Market by Value; 2021-2025 (US$ Billion)
Figure 6: Global Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 7: North America Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 8: North America Oral Insulin Market by Value; 2021-2025 (US$ Billion)
Figure 9: North America Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 10: The US Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 11: The US Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 12: Canada Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 13: Canada Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 14: Mexico Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 15: Mexico Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 16: Europe Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 17: Europe Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 18: Europe Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 19: Germany Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 20: Germany Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 21: UK Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 22: UK Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 23: France Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 24: France Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 25: Italy Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 26: Italy Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 27: Spain Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 28: Spain Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 29: Rest of Europe Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 30: Rest of Europe Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 31: Asia Pacific Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 32: Asia Pacific Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 33: Asia Pacific Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 34: China Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 35: China Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 36: Japan Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 37: Japan Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 38: India Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 39: India Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 40: Australia Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 41: Australia Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 42: South Korea Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 43: South Korea Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 44: Rest of Asia Pacific Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 45: Rest of Asia Pacific Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 46: ROW Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 47: ROW Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 48: ROW Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 49: Brazil Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 50: Brazil Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 51: Saudi Arabia Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 52: Saudi Arabia Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 53: South Africa Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 54: South Africa Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 55: ROW Countries Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 56: ROW Countries Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 57: Global Urban Population by Group of Economies; 2014-2050 (Million)
Figure 58: Global Number of People Suffering from Diabetes; 2011-2030 (Million)
Figure 59: Global Healthcare Spending; 2017-2022 (US$ Billion)
Figure 60: Novo Nordisk A/S Net Sales; 2016-2020 (US$ Billion)
Figure 61: Novo Nordisk A/S Net Sales by Segments; 2020 (Percentage, %)
Figure 62: Novo Nordisk A/S Net Sales by Region; 2020 (Percentage, %)
Figure 63: Oramed Pharmaceuticals Inc. Revenues; 2017-2020 (US$ Thousand)
Figure 64: vTv Therapeutics Revenue; 2018-2020 (US$ Million)
Table 1: Global Oral Insulin Market Players: A Financial Comparison; 2020
Table 2: Global Oral Insulin Market Players by Oral Drugs-related Clinical Trials; 2019
Companies Mentioned
- Novo Nordisk A/S
- Oramed Pharmaceuticals Inc.
- vTv Therapeutics
- Diabetology Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| Published | April 2021 |
| Forecast Period | 2021 - 2025 |
| Estimated Market Value ( USD | $ 1.36 Billion |
| Forecasted Market Value ( USD | $ 5.06 Billion |
| Compound Annual Growth Rate | 38.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 4 |
